Article Text

PDF
Contribution of the Epstein–Barr virus to the molecular pathogenesis of Hodgkin lymphoma
  1. G Kapatai,
  2. P Murray
  1. The Cancer Research UK Institute for Cancer Studies, Medical School, University of Birmingham, Birmingham, UK
  1. Dr P Murray, Department of Pathology, Division of Cancer Studies, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; p.g.murray{at}bham.ac.uk

Abstract

Although the morphology of the pathognomonic Reed–Sternberg cells of Hodgkin lymphoma (HL) was described over a century ago, it was not until recently that their origin from B lymphocytes was recognised. The demonstration that a proportion of cases of HL harbour the Epstein–Barr virus (EBV) and that its genome is monoclonal in these tumours suggests that the virus contributes to the development of HL in some cases. This review summarises current knowledge of the pathogenesis of HL with particular emphasis on the association with EBV.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared.

  • Funding: The Leukaemia Research Fund, Cancer Research UK and the Association for International Cancer Research provided support for this study.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.